- Research article
- Open Access
Lung progenitors from lambs can differentiate into specialized alveolar or bronchiolar epithelial cells
BMC Veterinary Researchvolume 9, Article number: 224 (2013)
Airways progenitors may be involved in embryogenesis and lung repair. The characterization of these important populations may enable development of new therapeutics to treat acute or chronic lung disease. In this study, we aimed to establish the presence of bronchioloalveolar progenitors in ovine lungs and to characterize their potential to differentiate into specialized cells.
Lung cells were studied using immunohistochemistry on frozen sections of the lung. Immunocytochemistry and flow cytometry were conducted on ex-vivo derived pulmonary cells. The bronchioloalveolar progenitors were identified by their co-expression of CCSP, SP-C and CD34. A minor population of CD34pos/SP-Cpos/CCSPpos cells (0.33% ± 0.31) was present ex vivo in cell suspensions from dissociated lungs. Using CD34 magnetic positive-cell sorting, undifferentiated SP-Cpos/CCSPpos cells were purified (>80%) and maintained in culture. Using synthetic media and various extracellular matrices, SP-Cpos/CCSPpos cells differentiated into either club cells (formerly named Clara cells) or alveolar epithelial type-II cells. Furthermore, these ex vivo and in vitro derived bronchioloalveolar progenitors expressed NANOG, OCT4 and BMI1, specifically described in progenitors or stem cells, and during lung development.
We report for the first time in a large animal the existence of bronchioloalveolar progenitors with dual differentiation potential and the expression of specialized genes. These newly described cell population in sheep could be implicated in regeneration of the lung following lesions or in development of diseases such as cancers.
It is now established that post-natal and adult lungs contain multiple progenitors or stem cell populations able to participate to organ homeostasis and repair . The relative distribution of these populations varies between species [2, 3] and these cells are difficult to evidence as the consequence of the low turn-over of the respiratory epithelium . The mouse system allowing the study of cell regeneration in response to chemical injury and more recently in vivo genetic lineage tracing [5, 6] has supplied a model to explore and describe epithelial lineages implicated in lung repair. Even so the murine pulmonary epithelium is rather different from the ones of the large mammals. In small mammals such as rodents, the proximal airways are composed of a layer comprising one or two cells thick that rests on a very sparse network of basal cells [7–10]. In large mammals, this epithelium is characterized by pseudo-stratified columnar cells together with ciliated, secretory, and parabasal cells linked to a foundation of basal cells [11, 12]. Moreover club cells, formerly named Clara cells [13–15] are present throughout the mouse airways while confined to the most distal bronchiolar airways in humans. Regeneration of alveolar tissue is rapid and efficient in rodents, but takes longer and needs higher level of stimulation in large mammals . Taking in account these observed differences on composition and temporal dynamics, the description of the resident progenitor populations is of importance in large mammals to better understand the building, maintenance and repair of the lung epithelium. Moreover, sheep have a long history as an experimental model to study respiratory diseases. These small ruminants have been proposed as good candidates for vaccine development as well as for comprehensive studies on asthma, bronchial obstruction or infant respiratory distress syndrome. It also provides a very useful model for respiratory infections and lung cancer.
Cystic fibrosis, chronic obstructive pulmonary disease and lung adenocarcinoma are part of the lung diseases that affect the distal lung and could appeal for progenitor or stem cell activation. The bronchioloalveolar region has been extensively studied in normal and injured lungs of rats and mice in response to chemical treatments. Undifferentiated cells in the bronchioloalveolar duct junction have been histologically identified as different from the alveolar epithelial type II cells (AECII), the club cells (Clara) or the ciliated cells . In mice, these bronchioloalveolar progenitors, referred as BASCs (BronchioloAlveolar Stem Cells), share phenotypic characteristics of both club cells and AECIIs, suggesting a niche of progenitors [2, 17–20]. They express CCSP (Club Cell Secretory Protein) specific of the club cells, SP-C (Surfactant Protein C), a component of the pulmonary surfactant produced by the AECII as well as CD34, a surface antigen of the hematopoietic stem cells [18, 21]. Murine BASCs appear to be resistant to bronchiolar and alveolar damage in vivo, proliferate during epithelial repair and have the potential to give rise to club cells and AECIs or AECIIs [18, 21]. Whether analogous pulmonary epithelial progenitors are present and could differentiate into specialized bronchiolar or alveolar cells in large animals is currently unknown.
We looked for bronchioloalveolar progenitors in sheep by ex vivo isolation of CD34pos/SP-Cpos/CCSPpos cells. Using CD34-magnetic positive cell selection, we isolated a SP-Cpos/CCSPpos viable cell population from the lungs of 0 to 3 month old lambs. Synthetic media and various extracellular matrix were used to establish the in vitro conditions to maintain SP-Cpos/CCSPpos cells in an undifferentiated and proliferative state or, alternatively, to induce their differentiation into either club cells or AECIIs. The bronchioloalveolar progenitors obtained ex vivo or maintained in vitro were further shown to express genes involved in stem cells or lung development such as NANOG (Nanog homeobox), OCT4 (Octamer-binding transcription factor 4) and BMI1 (polycomb ring finger oncogene). The expression of these genes was modulated upon exposure to culture conditions favoring cell differentiation.
In vivo description of SP-Cpos, CCSPpos and SP-Cpos/CCSPpospulmonary cells
The expression of SP-C and CCSP was analyzed in the lungs of 0 to 3 month old lambs by immunohistochemistry on frozen sections using cross-reacting antibodies. As expected, these antibodies specifically recognized cells expressing SP-C in the alveoli and cells expressing CCSP in the bronchioli (Figure 1A) validating their use as specific markers of respectively AECIIs and club cells in sheep. AECIIs were easily detectable in most of the sections due to their high expression of SP-C (Figure 1B) and club cells expressing CCSP were detectable when bronchioli were present on the lung section. Interestingly, rare SP-Cpos/CCSPpos cells were observed in some lung sections (Figure 1B), demonstrating the presence of bronchioloalveolar progenitors in newborn lambs. Among the 4 independent lungs and repeated immuno-stainings, the SP-Cpos/CCSPpos cells remained rare and only present on few lung sections. But this first in vivo evidence for the presence of progenitor-like pulmonary cells prompted us to search for these rare cells among cells obtained from lung dissociation.
To quantify the respective frequency of AECIIs, club cells and progenitors, cell suspensions obtained by enzymatic dissociation of lung tissue from 10 lambs (0 to 3 month old) were analyzed for their expression of SP-C and CCSP by flow cytometry. Based on the dot plot analysis from a representative lamb (Figure 1C) and the compiled data from 10 lambs (Figure 1D), the suspensions of lung cells repeatedly contained 40% (± 18.5) SP-Cpos cells and 0.65% (± 0.60) CCSPpos cells (Figure 1D). Co-expression of SP-C/CCSP was then analyzed to quantify the bronchioloalveolar progenitors. An average of 0.33% (± 0.31) of the total cells co-expressed the two markers and presented an immunophenotype compatible with lung progenitors (Figure 1D). We noted the low percentage of club cells in the cell suspensions issued from tissue dissociation. This may be attributed to our tissue processing. In order to work mainly with the cell populations present into the lung parenchyma, we carefully have macro-dissected the lung tissues before enzymatic digestion in order to limit cells coming from the bronchi and bronchioli. Moreover, the number of club cells in the lung of large mammals is lower compared to rodents.
In vitroexpansion and phenotypic characterization of primary airway epithelial cells
Dissociated cells were grown in culture with selective Quantum286 synthetic medium complemented with KGF and HGF (referred to "complete Q286 medium") on fibronectin-coated plates and maintained for two to three passages as previously described . Small and large cubical epithelial cell colonies and a few spindle-shaped cells were rapidly observed after 3 days of culture; the small cubical cells proliferated and were further characterized for the expression of SP-C and CCSP. As shown by specific labeling in immunocytochemistry and flow cytometry, a majority of the observed cubical cells were SP-Cpos AECIIs, while few of them were CCSPpos club cells (Figure 2A and 2B). Interestingly, a minor population of SP-Cpos/CCSPpos cells, compatible with bronchioloalveolar progenitors, was reproducibly identified in culture (Figure 2A and 2B). Compared to the AECIIs, the SP-Cpos/CCSPpos cells were semi-adherent round cells with small cytoplasmic extensions (Figure 2A). These double positive SP-Cpos/CCSPpos cells were rare after lung dissociation but enriched and maintained upon in vitro culture with synthetic medium (Figure 2B).
CD34 selection of bronchioloalveolar progenitors
To isolate and enrich a viable population of bronchioloalveolar progenitors, cells from ex vivo dissociated lungs were positively selected using anti-CD34 antibody-coated magnetic beads without any prior cell culture step. Cell surface expression of CD34, a surface protein expressed by some progenitors or stem cells, was then measured by flow cytometry to assess the enrichment of the bronchioloalveolar progenitor population in the selected population. In the 6 tested lambs, the CD34 cell sorting remarkably enriched the CD34pos population from 0.7% (± 0.12) after tissue dissociation to over 90% in the CD34-selected single cell suspension (Figure 3) with greater than 85% viability, as measured by trypan blue exclusion.
Expression of SP-C and CCSP among the CD34pos-selected population
To quantify the bronchioloalveolar progenitors among the CD34pos population, the selected cells were analyzed for the expression of CCSP and SP-C. By flow cytometry, the majority (over 80%) of the CD34pos cells co-expressed CCSP and SP-C with respectively 88% (± 6.8) and 84% (± 5.5) positive cells (Figure 4A and 4B). We assumed that hematopoietic stem cells or endothelial progenitors may contribute to the SP-Cneg and CCSPneg cells among the CD34pos population. Due to the nature of the antibodies used (i.e., polyclonal rabbit anti-proSP-C, mouse monoclonal or polyclonal rabbit anti-CCSP and monoclonal mouse anti-CD34), direct double labeling of SP-C and CCSP on the CD34pos population was not technically achievable. However, the large proportion of SP-Cpos/CD34pos and CCSPpos/CD34pos cells clearly demonstrated that most of the CD34pos cells were SP-Cpos/CCSPpos progenitors. The proportion of SP-Cpos/CCSPpos cells among the CD34pos population was similar in the 6 lambs analyzed independently (Figure 4B). Importantly, the proportion of CD34neg/SP-Cpos and CD34neg/CCSPpos cells was very low to undetectable in the CD34-sorted cell suspension (1.0% ± 1.7 and 1.1% ± 1.8, respectively), confirming that the procedure efficiently purified CD34pos cells and not AECIIs or club cells. Taken together, our results suggested that a bronchioloalveolar progenitor population exists in lambs and that these cells concomitantly express CD34, SP-C and CCSP.
To further characterize the CD34pos selected population, the mRNA expression of genes known to be preferentially but not exclusively expressed in stem cells, such as the self-renewal factor gene BMI1 and the pluripotent state-specific transcription factor genes OCT4 and NANOG, were analyzed. The expression of the housekeeping gene GAPDH was analyzed as a reference gene. Compared to the total cell suspensions obtained after lung dissociation, the CD34pos population expressed higher levels of BMI1, OCT4 and NANOG, suggesting the enrichment of progenitors during the purification process (Figure 4C). Interestingly, NANOG was almost absent from the unsorted population but was strongly expressed in the CD34pos-sorted cells (Figure 4C). Importantly, the expression of SP-C, CCSP and CD34 was maintained after CD34 selection (Figure 4C). Unfortunately the low number of cells obtained during the selection process did not allow us to further quantify the level of gene expression, due to the very low amounts of total RNA per analyzed sample.
In vitromaintenance of the ovine bronchioloalveolar progenitors
To assess their ability to proliferate in vitro, selected CD34pos progenitors were seeded onto inserts (membrane with 0.4 μm pore size) coated with fibronectin and type I and IV collagens and cultured with "complete Q286 medium" under “maintenance conditions" (Figure 5A, 5B and 5C). After 15 days, these CD34pos cells gave rise to small colonies of cubical epithelial cells, most of which expressed SP-C and CCSP (Figure 5A). The majority of these cells (>90%) maintained the co-expression of SP-C and CCSP for up to 3 passages (corresponding to approximately 45 days in culture) (Figure 5B and 5C). When maintenance conditions were applied to cells from 6 independent animals, the same proportions of SP-Cpos/CCSPpos cells were generated, and this population of bronchiololaveolar progenitors was maintained over time (Figure 5C). While SP-C and CCSP expression persisted, the overall fluorescence intensity of these two markers decreased over time to reach a lower but easily detectable signal after 3 passages.
From bronchioloalveolar progenitors to differentiated epithelial pulmonary cells in vitro
In addition to their self-renewing properties, progenitors must be able to differentiate into multiple cell types under specific conditions. Indeed, using synthetic medium and adapted cell culture conditions, CD34pos/SP-Cpos/CCSPpos bronchioloalveolar progenitors had the potential to differentiate into either AECIIs or club cells. To induce the differentiation of SP-Cpos/CCSPpos cells into AECIIs, CD34pos cells were seeded onto plates coated with fibronectin and type I and IV collagens and cultured with "complete Q286 medium", culture conditions that we defined as "AECII conditions". Along 3 passages (approximately 45 days), we observed a noticeable increase of the proportion of cell expressing SP-Cpos/CCSPneg (Figure 5A and B), whereas the SP-Cpos/CCSPpos population decreased over time (Figure 5C). Cultures from 6 independent animals showed the same modulation with an increasing proportion of SP-Cpos/CCSPneg AECIIs (from < 5% to 58%; Figure 5C). In contrast, the population of SP-Cpos/CCSPpos progenitors rapidly decreased throughout the passages from over 90% to less than 30% (Figure 5C). Under these conditions, no CCSPpos cells emerged from the initial SP-Cpos/CCSPpos population. Because we have previously shown that none to less than 1% (± 1.7) of the CD34neg/SP-Cpos AECII were present after CD34 positive selection, our findings strongly argue for the in vitro differentiation of bronchioloalveolar progenitors into AECIIs and not the mere proliferation of pre-existing AECIIs.
Conversely, CD34pos progenitors cultured in "basic Q286 medium" (without KGF and HGF) on fibronectin-coated plates, conditions that we defined as "club cell conditions" gave rise to colonies containing primarily SP-Cneg/CCSPpos cells (53.6% ± 13) after 15 days in culture (Figure 5A, 5B and 5C). Concurrently, SP-Cpos/CCSPpos bronchioloalveolar progenitors (24.9% ± 14) rapidly decreased, while SP-Cpos/CCSPneg AECIIs remained low to undetectable (5% ± 8; Figure 5C). Similarly to the AECII conditions, we have previously shown that none to less than 1.1 (± 1.8%) of the CD34neg/CCSPpos club cells were present after CD34 positive selection from the 6 tested lambs, strongly suggesting the in vitro differentiation of bronchioloalveolar progenitors into club cells. Together with the low proliferation rate of CCSPpos cells in the cultures, our findings strongly argue for the differentiation of bronchioloalveolar progenitors into club cells rather than the proliferation of already existing club cells in the cultures.
Expression of NANOG, OCT4 and BMI1
As previously mentioned, the expression of NANOG and OCT4 is a strong indicator of a stem cell/ progenitor phenotype. NANOG and OCT4 were expressed in the CD34pos/SP-Cpos/CCSPpos cells enriched from dissociated tissues (Figure 4C). To further characterize the CD34pos cells that were maintained in vitro and differentiated, RT-PCR was used to analyze the expression of OCT4, NANOG and BMI1 in the progenitors maintained in culture and in the different enriched, but not pure, cultures of AECIIs and club cells derived from 3 lambs (#1729, #1730, #1731) at passage 1 (Figure 6A). BMI1 was expressed at various levels and predominantly in the medium that favored the differentiation of bronchioloalveolar progenitors into AECIIs (Figure 6B). Importantly, this first passage still contained SP-Cpos/CCSPpos progenitors. Interestingly, OCT4 was expressed in the “maintenance conditions” that favored expansion of bronchioloalveolar progenitors, in which greater than 70% of the cells displayed a SP-Cpos/CCSPpos phenotype. In the differentiation conditions that generated AECIIs or club cells, OCT4 expression was strongly reduced in 2 of the 3 lambs. However, in lamb #1730, some expression of OCT4 was detectable in cells cultured in “AECII conditions”, which is compatible with the lower proportion of SP-Cpos/CCSPneg AECIIs compared to the 2 others lambs at passage 1 (Figure 6A). This result suggests that OCT-4 expression was characteristic of cell progenitors and that its expression was lost upon differentiation. Surprisingly, the expression of NANOG appeared to be less stable in the bronchioloalveolar progenitors maintained in vitro (Figure 6) compared to the ones obtained ex vivo, as previously described (Figure 4C), suggesting that the cultured SP-Cpos/CCSPpos cells rapidly underwent a differentiation step.
In this study, we described the presence of SP-Cpos/CCSPpos progenitors in the lung parenchyma of 0-3 month-old lambs. These rare cells (~0.3% of the pulmonary epithelial cells) have been isolated after tissue dissociation and they co-expressed CD34, SP-C and CCSP. The SP-Cpos/CCSPpos cells were maintained in vitro for up to 2 or 3 passages (30-45 days). Pluripotent progenitors are defined by their ability to maintain and differentiate upon exposure to specific stimuli. To further characterize the ovine SP-Cpos/CCSPpos cells, we first performed positive selection for CD34 expression, a surface protein widely described on various stem cells and present on ovine hematopoietic stem/progenitor cells . A small population of cells (few thousand) was isolated and characterized as SP-Cpos/CCSPpos cells. They expressed mRNAs for the NANOG, OCT4 and BMI1 genes which are molecular markers of stem cells/progenitors. They retained the expression of SP-C, CCSP and CD34 mRNAs over time. Importantly, the CD34pos/SP-Cpos/CCSPpos cells were able to maintain for up to 3 passages in vitro. The CD34pos/SP-Cpos/CCSPpos cell population retained the potential to differentiate at least into AECIIs or club cells in specific culture conditions. The CD34pos/SP-Cpos/CCSPpos cells, maintained in vitro, expressed OCT4 and BMI1 mRNAs, conferring them characteristics inherent to multipotent cells or progenitors.
Bronchioloalveolar progenitors have been reported in mice in an anatomically well-defined location at the bronchioloalveolar junction where conducting and respiratory airways meet [18, 24, 25]. These cells were initially described by their expression of Sca-1 and CD34, and their co-expression of SP-C and CCSP. We succeeded in demonstrating the in vivo presence of rare ovine bronchioloalveolar progenitors in the lungs of newborn or young animals (less than 3 months old), while other groups have difficulties to identify bronchioloalveolar progenitors in sheep upon searching for these cells using CCSP and SP-C immunostaining on lung sections [26, 27]. Interestingly, two studies have reported rare to extremely rare SP-Cpos/CCSPpos cells in virally-induced lung tumors in sheep [26, 28]. Taken together, these results are consistent with the presence of SP-Cpos/CCSPpos cell population, extremely rare in vivo on frozen lung sections and representing a new progenitor population. The discrepancy between our study and previous studies [26, 27] may be explained by the low but clearly above background levels of SP-C and CCSP expression in double-positive cells compared to the expression of these markers in AECIIs and club cells, respectively. Moreover, a recent study on ovine lung sections, have shown that CCSPpos cells were not (preterm lung) or poorly (9 days old lung) detectable in prenatal and early postnatal lung compared to mature lung (91 days) in bronchi, terminal bronchioles and respiratory bronchiole . These elements point the influence of the age of the lung studied, in the search for postnatal bronchioloalveolar CCSPpos/SP-Cpos progenitors.
The visualization of double-positive cells in the complex lung is therefore challenging and the CD34 enrichment strategy enabled us to evidence and to study this progenitor population. In addition, bronchioloalveolar progenitors may be more easily identified in lungs from newborn lambs. Of note, we have previously reported the presence of SP-Cpos/CCSPpos cells in the sheep lung while describing the ex vivo isolation of tumoral AECIIs from a virus-induced lepidic lung adenocarcinoma . While culturing these cells in three-dimensional conditions, better adapted to these polarized and specialized cells, we repeatedly observed SP-Cpos/CCSPpos double-positive cells (data not shown). These results prompted us to go further into their characterization.
SP-Cpos/CCSPpos double-positive bronchioloalveolar progenitors are rare and represent less than 0.4% of the total epithelial cells from dissociated lungs. In comparison, a recent study has established that undifferentiated human stem cells identified by c-kit immunosorting are present at a frequency of 1 per 6,000 cells in the bronchioles and 1 per 30,000 cells in the alveoli in adults . In fetal human lung tissue at 12-36 weeks of gestation, the frequency of stem cells varies from 1 per 11,000 to 1 per 600 cells, with an average of 1 per 4,100 cells . Our CD34-positive selection procedure was crucial to isolate bronchioloalveolar progenitors from the lung even though the absolute number of CD34pos/SP-Cpos/CCSPpos cells was ultimately low (only a few thousands cells) and confirmed the existence of a rare population of SP-Cpos/CCSPpos bronchioloalveolar progenitors. Importantly, all of the selection steps were performed ex vivo, without any cell culture steps and in the absence of fetal calf serum known to induce cell differentiation.
The CD34pos/SP-Cpos/CCSPpos population resembles the now well-characterized murine bronchioloalveolar stem cells in terms of both morphology and cell markers [18, 24, 25]. We clearly demonstrated that ovine bronchioloalveolar progenitors behave as multipotent precursors in culture and have maintenance and differentiation potential upon modulation of the culture conditions.
We then demonstrated that the ex vivo-derived ovine bronchioloalveolar progenitors retained the expression of the BMI1, OCT4 and NANOG genes which are some of the most important markers of undifferentiated pluripotent cells and are major players in embryonic and adult stem cells. BMI1 is a member of the PcG family of transcription repressors that play crucial roles in development, stem cell biology and cancer . BMI1 is also highly expressed in tumors and regulates the cell fate of cancer cells and normal and tumoral stem cells [32, 33]. BMI1 participates in the maintenance of endogenous stem cells, partly by repressing genes involved in cell death and senescence . In mice, BMI1 is necessary for bronchioloalveolar stem cells expansion . Similarly to murine bronchioloalveolar stem cells, ovine bronchioloalveolar progenitors expressed BMI1 under maintenance/self-renewing conditions, and this expression was not modified by exposure to differentiation conditions.
While OCT4, a member of the POU (Pit-Oct-Unc) transcription factor family, is essential for the maintenance of self-renewal capacities, NANOG (a downstream target of OCT4) contributes to the cell fate determination of pluripotent cells during embryogenesis [36, 37]. OCT4 and NANOG are among the few key factors that enable the reprogramming of adult somatic cells into pluripotent stem cells [38–42]. Interestingly, induced pluripotent cells (iPSCs) generated from sheep fibroblasts have recently been demonstrated to exhibit an embryonic stem cell-like morphology and to express OCT4 and NANOG among other intracellular and surface markers associated with undifferentiated cells, as previously demonstrated in humans and mice . The level of OCT4 is critical for the state of a cell and its inactivation results in the loss of pluripotency and induces differentiation . We could observe a loss or reduction of OCT4 gene expression in AECII and club cells compared to progenitors. OCT4 and NANOG are expressed in lung stem cells, and their co-expression may enhance malignancy by inducing cancer stem cell-like properties [45, 46]. Surprisingly, NANOG gene expression was higher in AECII and club cells than in progenitors in our in vitro culture conditions. NANOG expression is known to be regulated by a number of pluripotent transcription factors (FoxD3, SOX2, OCT4) . It is likely that this complex regulation is also dependent of the in vitro context (growth factors, monolayer or 2D culture conditions) and others active signaling cascades . With respect to the recently described human c-kit lung stem cell , it would be interesting to study the expression of c-kit in lamb lung sections and in the SP-Cpos/CCSPpos bronchioloalveolar progenitors population to better understand the hierarchical organization of these progenitors in this complex tissue.
We report here the first direct characterization of CD34pos/SP-Cpos/CCSPpos bronchioloalveolar progenitors from the lung of a large animal. While extremely rare, these cells can be purified and enriched from the lungs of newborn lambs. These cells have a potential to maintain and differentiate in highly specialized epithelial cells. The SP-Cpos/CCSPpos bronchioloalveolar progenitors express progenitor markers, such as the NANOG, BMI1 and OCT4 genes, in vivo and in vitro, indicating that newborn lung progenitors retain characteristics typical of progenitors residing in the developing organ. Although dealing with a limited number of cells, these data enable the study of the development of the bronchiolar and alveolar epithelia. Sheep, an alternative animal model closer to humans than mice, are already largely used to study lung physiology and pathology. In this context, ovine bronchioloalveolar progenitors may represent new tools to study lung regeneration or new therapeutic targets.
Lungs were collected from 10 young lambs either from 3 month old animals at the Corbas slaughterhouse (Corbas, Rhône, France), with the formal authorization for the access to the facility and under the supervision of Dr F. Guiguen (DVM) or from stillborn lambs from healthy ewes belonging to the flock providing lambs and sheep to the experimental infectious disease platform of the INRA Animal Health Division, Tours France; these lungs have been sampled by qualified staff and DVM of the core facility. None of the animals used in this study were engaged into an experimental protocol.
Immediately after death, fractions of the lungs were processed as previously described . Lungs were minced into small pieces and incubated in 10 μg/ml of DNAse I, 1 mg/ml protease XIV and 0.025% collagenase Ia for 2 h at 37°C, filtered through 100 μm and 40 μm cell strainers and centrifuged at 450 g for 10 min at 4°C. The cell pellets were collected in a red blood cell lysis buffer (0.15 M NH4Cl, 10 mM KHCO3, 0.1 mM EDTA) for 2 minutes, washed and re-suspended in 1X PBS supplemented with 4% of fetal calf serum. Cell number, concentration and viability were tested by trypan blue dye exclusion test on Malassez Chamber and were later confirmed by flow cytometry analysis upon propidium iodide (1 mg/ml, Sigma) staining.
Enrichment of pulmonary CD34poscells
Aliquots of 107 dissociated cells were labeled using an indirect CD34 labeling technique with magnetic beads attached to a secondary antibody. Briefly, according to the manufacturer's instructions (Miltenyi Biotech), the cells were incubated with a 1:200 dilution of mouse anti-sheep CD34 antibodies (clone Eq8D11C1 kindly provided by Pr CD Porada, University of Nevada) for 15 min on ice, washed in a buffer containing 1X PBS, 2 mM EDTA and 0.5% bovine serum albumin. The mixture was then incubated for 15 min on ice with goat anti-mouse IgG microbeads (Miltenyi France) at a 1:5 dilution in 1X PBS, 2 mM EDTA, and 0.5% bovine serum albumin. The suspension was washed and centrifuged at 450 g for 10 min at 4°C. For the magnetic separation, Mini Macs separation columns (Miltenyi France) were rinsed with 500 μl of cold 1X PBS, 2 mM EDTA and 0.5% bovine serum albumin. The cell pellets were re-suspended at 107 cells per 500 μl of the same buffer and poured into the column reservoir. The CD34 positive (CD34pos) cells were retained onto the magnetized matrix of the column, whereas the non-labeled cells passed through and were collected as the “non-retained” fraction. The columns were rinsed three times with 500 μl of 1X PBS, 2 mM EDTA and 0.5% bovine serum albumin. In order to collect the CD34pos cells, the column were removed from the magnetic field and were washed by gravity with 1.5 ml of 1X PBS, 2 mM EDTA.
Gene expression analysis of NANOG, BMI1 and OCT4 mRNAs by RT-PCR
Total RNAs were isolated using the RNeasy Mini kit (Qiagen, France) and 200 ng of total RNAs were reverse transcribed into cDNA using the iScript cDNA Synthesis kit (Bio-Rad, France). Specific primers for ovine GAPDH, BMI1, OCT4 and NANOG were designed as follows (from 5' to 3'): GAPDH FOR CCACCAACTGCTTGGCCCCC, GAPDH REV CCTCGGCCATCACGCCACAG, SP-C FOR GCAACGCCTGGCCCTGAGT, SP-C REV CATAATGTAGCAGCAGGTTC, CCSP FOR GTCACCCTGACTCTCTTCTG, CCSP REV CAGGGCTGAAAGGTTCCAGG, CD34 FOR GATTGCACTGGTCACCTCG, CD34 REV CTCCACGTAATAAGGGTCTTC, OCT4 FOR CAAGAACATGTGTAAGCTGC, OCT4 REV CGATACTCGTCCGCTTTCTC, NANOG-for GGCAGAAAAACAACTGGCCGAGGAA, NANOG REV CCCCACATGGGCAGGTTTCCAG, BMI1 FOR GCCACAACCATAATAGAATGTC and BMI1 REV CCCTGGAACTAATTTGTATAC. The PCR reactions were performed using 10 ng of cDNA with the KAPA SYBR FAST kit (Cliniscience, France) as recommended.
In vitrocell cultures of total primary cells, bronchioloalveolar progenitors, AEC II and club cells
After tissue dissociation, 1.6 × 105 cells were seeded per well in 6-well plates previously coated with 10 mg/ml of fibronectin (Sigma), 1 μg/ml of type I collagen (Sigma) and 5 mg/ml of type IV collagen (Sigma) in Quantum 286 medium (PAA, Austria) supplemented with 5 ng/ml of HGF (Hepatocyte Growth Factor; Abcys), 10 ng/ml of KGF (Keratinocyte Growth Factor; Abcys), penicillin and streptomycin (named "complete Q286 medium") as previously reported  and maintained for 2 to 3 passages.
To amplify the bronchioloalveolar precursors, 5 × 103 CD34pos cells were seeded per insert (membrane with pore size of 0,4 μm) placed in 24-well plates coated with fibronectin and type I and IV collagens in "complete Q286 medium" and maintained for 2 to 3 passages. These culture conditions with specific medium and extracellular matrix had been defined as the "maintenance conditions".
In order to induce their differentiation into AECII, 5 × 103 CD34pos cells per well were directly seeded in 24 well plates coated with fibronectin, and type I and IV collagens with "complete Q286 medium" and maintained in culture up to 3 to 4 passages. These culture conditions had been defined as the "AECII conditions". For their differentiation into club cells, 5 × 103 CD34pos cells per well were seeded in 24 well plates coated with only 10 mg/ml of fibronectin and maintained in Quantum 286 without additional KGF and HGF (then named "basic Q286 medium") for 1 passage. These culture conditions had been defined as the "Club cell conditions".
The sorted cells were characterized for their expression of SP-C and CCSP by flow cytometry. After their elution from the columns, cells were rinsed in the 1X PBS and 4% fetal calf serum then centrifuged at 450 g 10 min at 4°C. Aliquots of 1.105 cells were stained with a 1:600 dilution of a rabbit anti-human proSP-C polyclonal serum (Millipore, AB3786) and a 1:500 dilution of mouse anti-human CCSP monoclonal antibodies (Abnova H00007356-M01). After incubation at 4°C for 1 hour, cells were stained with goat anti-rabbit IgGs conjugated to Alexa 488 (InVitrogen) and/or goat anti-mouse IgGs (Whole molecule) conjugated to R-Phycoerythrin (Sigma) for 30 minutes, at 4°C in the dark. Stained cells were centrifuged at 1000 g for 2 min at 4°C then fixed with 2% paraformaldehyde before flow cytometry quantification on a Becton Dickson FACSCalibur™ Flow cytometer and analysis using the CellQuest Pro software. To avoid signal overflow a color compensation of 10 to 23% was applied. Populations of interest were gated regarding their physical properties (forward and size scatters) to eliminate dead cells and cell debris. Immunostaining using only the secondary antibody were used as controls to adjust the detection threshold for each measured wavelength.
Expression of CCSP and SP-C was analyzed on fixed cultured cells or frozen lung sections. After fixation with 4% paraformaldehyde, cells or tissue sections were permeabilized with 0.2% Triton X100, washed with 1X PBS and incubated 1 h, at room temperature with a 1:600 dilution of a rabbit anti-human proSP-C polyclonal serum or a 1:500 dilution mouse anti-human CCSP monoclonal antibodies. Cells were then washed and stained with goat anti-rabbit IgGs conjugated to Alexa 488 or anti-mouse IgGs conjugated to R-phycoerythrin for 30 minutes, at 4°C in the dark. The nuclei had been stained with DAPI. As negative controls, labeling was conducted without primary antibodies. The slides were analyzed on an AxioImager Microscope (Zeiss).
Club Cell Secretory Protein
Alveolar Epithelial type I Cell
Alveolar Epithelial type II Cell
Octamer-binding Transcription factor 4
B lymphoma Mo-MLV insertion region 1 homolog.
Rock JR, Hogan BL: Epithelial progenitor cells in lung development, maintenance, repair, and disease. Annu Rev Cell Dev Biol. 2011, 27: 493-512.
Rawlins EL, Hogan BL: Epithelial stem cells of the lung: privileged few or opportunities for many?. Development. 2006, 133: 2455-2465.
Rock JR, Randell SH, Hogan BL: Airway basal stem cells: a perspective on their roles in epithelial homeostasis and remodeling. Dis Model Mech. 2010, 3: 545-556.
Kauffman SL: Cell proliferation in the mammalian lung. Int Rev Exp Pathol. 1980, 22: 131-191.
Rock JR, Onaitis MW, Rawlins EL, Lu Y, Clark CP, Xue Y, Randell SH, Hogan BL: Basal cells as stem cells of the mouse trachea and human airway epithelium. Proc Natl Acad Sci USA. 2009, 106: 12771-12775.
Tropea KA, Leder E, Aslam M, Lau AN, Raiser DM, Lee JH, Balasubramaniam V, Fredenburgh LE, Alex Mitsialis S, Kourembanas S, Kim CF: Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2012, 302: L829-L837.
Evans MJ, Cox RA, Shami SG, Wilson B, Plopper CG: The role of basal cells in attachment of columnar cells to the basal lamina of the trachea. Am J Respir Cell Mol Biol. 1989, 1: 463-469.
Plopper CG, Mariassy AT, Lollini LO: Structure as revealed by airway dissection. A comparison of mammalian lungs. Am Rev Respir Dis. 1983, 128: S4-S7.
Plopper CG, Mariassy AT, Wilson DW, Alley JL, Nishio SJ, Nettesheim P: Comparison of nonciliated tracheal epithelial cells in six mammalian species: ultrastructure and population densities. Exp Lung Res. 1983, 5: 281-294.
Rackley CR, Stripp BR: Building and maintaining the epithelium of the lung. J Clin Invest. 2012, 122: 2724-2730.
Harkema JR, Mariassy A, George JS, Hyde DM, Plopper CG: Epithelial Cells in the Conducting Airways : A Species Comparison. The airway epithelium: Physiology, pathophysiology and pharmacology. 1991, New York, NY, USA: Marcel Dekker
Mariassy AT, Plopper CG: Tracheobronchial epithelium of the sheep: I. Quantitative light-microscopic study of epithelial cell abundance, and distribution. Anat Rec. 1983, 205: 263-275.
Irwin RS, Augustyn N, French CT, Rice J, Tedeschi V, Welch SJ, Editorial Leadership T: Spread the word about the journal in 2013: from citation manipulation to invalidation of patient-reported outcomes measures to renaming the Clara cell to new journal features. Chest. 2013, 143: 1-4.
Winkelmann A, Noack T: The Clara cell: a "Third Reich eponym"?. Eur Respir J. 2010, 36: 722-727.
Woywodt A, Lefrak S, Matteson E: Tainted eponyms in medicine: the "Clara" cell joins the list. Eur Respir J. 2010, 36: 706-708.
Hsia CC: Signals and mechanisms of compensatory lung growth. J Appl Physiol. 2004, 97: 1992-1998.
Wuenschell CW, Sunday ME, Singh G, Minoo P, Slavkin HC, Warburton D: Embryonic mouse lung epithelial progenitor cells co-express immunohistochemical markers of diverse mature cell lineages. J Histochem Cytochem. 1996, 44: 113-123.
Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, Crowley D, Bronson RT, Jacks T: Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell. 2005, 121: 823-835.
McQualter JL, Yuen K, Williams B, Bertoncello I: Evidence of an epithelial stem/progenitor cell hierarchy in the adult mouse lung. Proc Natl Acad Sci USA. 2010, 107: 1414-1419.
Rawlins EL: Lung epithelial progenitor cells: lessons from development. Proc Am Thorac Soc. 2008, 5: 675-681.
Nolen-Walston RD, Kim CF, Mazan MR, Ingenito EP, Gruntman AM, Tsai L, Boston R, Woolfenden AE, Jacks T, Hoffman AM: Cellular kinetics and modeling of bronchioalveolar stem cell response during lung regeneration. Am J Physiol Lung Cell Mol Physiol. 2008, 294: L1158-L1165.
Archer F, Jacquier E, Lyon M, Chastang J, Cottin V, Mornex JF, Leroux C: Alveolar type II cells isolated from pulmonary adenocarcinoma: a model for JSRV expression in vitro. Am J Respir Cell Mol Biol. 2007, 36: 534-540.
Porada CD, Harrison-Findik DD, Sanada C, Valiente V, Thain D, Simmons PJ, Almeida-Porada G, Zanjani ED: Development and characterization of a novel CD34 monoclonal antibody that identifies sheep hematopoietic stem/progenitor cells. Exp Hematol. 2008, 36: 1739-1749.
McQualter JL, Brouard N, Williams B, Baird BN, Sims-Lucas S, Yuen K, Nilsson SK, Simmons PJ, Bertoncello I: Endogenous fibroblastic progenitor cells in the adult mouse lung are highly enriched in the sca-1 positive cell fraction. Stem Cells. 2009, 27: 623-633.
Snyder JC, Teisanu RM, Stripp BR: Endogenous lung stem cells and contribution to disease. J Pathol. 2009, 217: 254-264.
Martineau HM, Cousens C, Imlach S, Dagleish MP, Griffiths DJ: Jaagsiekte sheep retrovirus infects multiple cell types in the ovine lung. J Virol. 2011, 85: 3341-3355.
Murgia C, Caporale M, Ceesay O, Di Francesco G, Ferri N, Varasano V, de las Heras M, Palmarini M: Lung adenocarcinoma originates from retrovirus infection of proliferating type 2 pneumocytes during pulmonary post-natal development or tissue repair. PLoS Pathog. 2011, 7: e1002014.
Platt JA, Kraipowich N, Villafane F, DeMartini JC: Alveolar type II cells expressing jaagsiekte sheep retrovirus capsid protein and surfactant proteins are the predominant neoplastic cell type in ovine pulmonary adenocarcinoma. Vet Pathol. 2002, 39: 341-352.
Martineau HM, Dagleish MP, Cousens C, Underwood C, Forbes V, Palmarini M, Griffiths DJ: Cellular differentiation and proliferation in the ovine lung during gestation and early postnatal development. J Comp Pathol. 2013, 149 (2-3): 225-267.
Kajstura J, Rota M, Hall SR, Hosoda T, D'Amario D, Sanada F, Zheng H, Ogorek B, Rondon-Clavo C, Ferreira-Martins J, et al: Evidence for human lung stem cells. N Engl J Med. 2011, 364: 1795-1806.
Bracken AP, Helin K: Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat Rev Canc. 2009, 9: 773-784.
Kimura M, Takenobu H, Akita N, Nakazawa A, Ochiai H, Shimozato O, Fujimura Y, Koseki H, Yoshino I, Kimura H, et al: Bmi1 regulates cell fate via tumor suppressor WWOX repression in small-cell lung cancer cells. Canc Sci. 2011, 102: 983-990.
Liu X, Driskell RR, Engelhardt JF: Stem cells in the lung. Meth Enzymol. 2006, 419: 285-321.
Grinstein E, Mahotka C: Stem cell divisions controlled by the proto-oncogene BMI-1. J Stem Cells. 2009, 4: 141-146.
Dovey JS, Zacharek SJ, Kim CF, Lees JA: Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion. Proc Natl Acad Sci USA. 2008, 105: 11857-11862.
Cavaleri F, Scholer HR: Nanog: a new recruit to the embryonic stem cell orchestra. Cell. 2003, 113: 551-552.
Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, Smith A: Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell. 2003, 113: 643-655.
Li Y, Zhao H, Lan F, Lee A, Chen L, Lin C, Yao Y, Li L: Generation of human-induced pluripotent stem cells from gut mesentery-derived cells by ectopic expression of OCT4/SOX2/NANOG. Cell Reprogram. 2010, 12: 237-247.
Okita K, Ichisaka T, Yamanaka S: Generation of germline-competent induced pluripotent stem cells. Nature. 2007, 448: 313-317.
Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ: Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2008, 451: 141-146.
Sumer H, Liu J, Malaver-Ortega LF, Lim ML, Khodadadi K, Verma PJ: NANOG is a key factor for induction of pluripotency in bovine adult fibroblasts. J Anim Sci. 2011, 89: 2708-2716.
Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, et al: Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007, 318: 1917-1920.
Li Y, Cang M, Lee AS, Zhang K, Liu D: Reprogramming of sheep fibroblasts into pluripotency under a drug-inducible expression of mouse-derived defined factors. PLoS One. 2011, 6: e15947.
Niwa H, Miyazaki J, Smith AG: Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet. 2000, 24: 372-376.
Chiou SH, Wang ML, Chou YT, Chen CJ, Hong CF, Hsieh WJ, Chang HT, Chen YS, Lin TW, Hsu HS, Wu CW: Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Canc Res. 2010, 70: 10433-10444.
Ling TY, Kuo MD, Li CL, Yu AL, Huang YH, Wu TJ, Lin YC, Chen SH, Yu J: Identification of pulmonary Oct-4+ stem/progenitor cells and demonstration of their susceptibility to SARS coronavirus (SARS-CoV) infection in vitro. Proc Natl Acad Sci USA. 2006, 103: 9530-9535.
Pan G, Thomson JA: Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res. 2007, 17: 42-49.
Miyanari Y, Torres-Padilla ME: Control of ground-state pluripotency by allelic regulation of Nanog. Nature. 2012, 483: 470-473.
Funding from the Ligue Nationale de Recherche sur le Cancer (Ardèche committee), and Rhône Alpes Region. The “Platim” and “AniRA – Flow cytometry” platforms are part of the UMS 3444 SFR BioSciences Gerland-Lyon Sud. AAR was the recipient of an AUF (Agence Universitaire de la Francophonie) PhD. fellowship and received financial support from Saint Esprit de Kaslik University, Lebanon.
The authors FA, AAR, SD, CD, BG, FG, VC and CL declare that they have no competing interests. The author JFM declares being consultant for LFB.
FA: conception, design, acquisition, analysis and interpretation of the data; drafting of the manuscript, writing the article, revising it for intellectual content and final approval. AAR: design, acquisition, analysis and interpretation of the data, first draft. SD, CD, BG and FG: Acquisition and analysis of the data and final approval of the article. VC: Contributed to the conception and design of the experiments, revising the manuscript and final approval. JFM: Contributed to the conception of the study; drafting of the manuscript and revising it for intellectual content and final approval. CL: Conception and design of the experiments, acquisition of the data, analysis and interpretation of the data, drafting of the manuscript, writing the article, final approval and revision for intellectual content. All authors read and approved the final manuscript.
Fabienne Archer, Alain Abi-Rizk contributed equally to this work.